The Contribution of Lipotoxicity to Diabetic Kidney Disease

被引：31
|
作者：
Schelling, Jeffrey R. [1 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA
来源：
CELLS | 2022年 / 11卷 / 20期
关键词：
cholesterol esters; diabetic kidney disease; fatty acids; lipid droplets; podocyte; proximal tubule; RENAL LIPID-METABOLISM; TUBULAR EPITHELIAL-CELLS; ENDOPLASMIC-RETICULUM STRESS; BOUND FATTY-ACIDS; PROXIMAL TUBULE; CANNABINOID RECEPTOR; INJURY MOLECULE-1; FENOFIBRATE THERAPY; PODOCYTE INJURY; LDL CHOLESTEROL;
D O I：
10.3390/cells11203236
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Lipotoxicity is a fundamental pathophysiologic mechanism in diabetes and non-alcoholic fatty liver disease and is now increasingly recognized in diabetic kidney disease (DKD) pathogenesis. This review highlights lipotoxicity pathways in the podocyte and proximal tubule cell, which are arguably the two most critical sites in the nephron for DKD. The discussion focuses on membrane transporters and lipid droplets, which represent potential therapeutic targets, as well as current and developing pharmacologic approaches to reduce renal lipotoxicity.
引用
收藏
页数：19
相关论文
共 50 条
  • [1] Podocyte lipotoxicity in diabetic kidney disease
    Nishi, Hiroshi
    Nangaku, Masaomi
    KIDNEY INTERNATIONAL, 2019, 96 (04) : 809 - 812
  • [2] Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease
    Nicholson, Rebekah J.
    Pezzolesi, Marcus G.
    Summers, Scott A.
    FRONTIERS IN ENDOCRINOLOGY, 2021, 11
  • [3] CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease
    Zuo, Fuwen
    Wang, Youzhao
    Xu, Xinlei
    Ding, Ruihao
    Tang, Wei
    Sun, Yu
    Wang, Xiaojie
    Zhang, Yan
    Wu, Jichao
    Xie, Yusheng
    Liu, Min
    Wang, Ziying
    Yi, Fan
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 150
  • [4] Mitochondrial Contribution to Inflammation in Diabetic Kidney Disease
    Mitrofanova, Alla
    Fontanella, Antonio M.
    Burke, George W.
    Merscher, Sandra
    Fornoni, Alessia
    CELLS, 2022, 11 (22)
  • [5] Genetic Contribution to Risk for Diabetic Kidney Disease
    Rich, Stephen S.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (08): : 1135 - 1137
  • [6] The Evolving Understanding of the Contribution of Lipid Metabolism to Diabetic Kidney Disease
    Krisztian Stadler
    Ira J. Goldberg
    Katalin Susztak
    Current Diabetes Reports, 2015, 15
  • [7] Combination of canagliflozin and puerarin alleviates the lipotoxicity to diabetic kidney in mice
    Zhu, Qian
    Zhou, Qu
    Luo, Xiao-li
    Zhang, Xu-jie
    Li, San-yu
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2023, 27 (03): : 221 - 230
  • [8] Contribution of mitochondrial gene variants in diabetes and diabetic kidney disease
    Li, Meng
    Gong, Siqian
    Han, Xueyao
    Zhou, Lingli
    Zhang, Simin
    Ren, Qian
    Cai, Xiaoling
    Luo, Yingying
    Liu, Wei
    Zhu, Yu
    Zhou, Xianghai
    Li, Yufeng
    Ji, Linong
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [9] The Evolving Understanding of the Contribution of Lipid Metabolism to Diabetic Kidney Disease
    Stadler, Krisztian
    Goldberg, Ira J.
    Susztak, Katalin
    CURRENT DIABETES REPORTS, 2015, 15 (07)
  • [10] Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease
    Falkevall, Annelie
    Mehlem, Annika
    Palombo, Isolde
    Sahlgren, Benjamin Heller
    Ebarasi, Lwaki
    He, Liqun
    Ytterberg, A. Jimmy
    Olauson, Hannes
    Axelsson, Jonas
    Sundelin, Birgitta
    Patrakka, Jaakko
    Scotney, Pierre
    Nash, Andrew
    Eriksson, Ulf
    CELL METABOLISM, 2017, 25 (03) : 713 - 726
12345